We are live on ! Find out more
QNME

Quanome Technologies

0.7385 USD
-0.0662
8.23%
At close Updated Sep 25, 4:00 PM EDT
Pre-market
After hours
0.7133
-0.0252
3.41%
1 day
-8.23%
5 days
58.82%
1 month
132.38%
3 months
67.84%
6 months
-9.25%
Year to date
-17.02%
1 year
-45.7%
5 years
-81.58%
10 years
-81.58%
 

About: Quanome Technologies Inc is a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea.

Employees: 94

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 33.3%
Neutral 66.7%
Negative 0%
Neutral
GlobeNewsWire
3 days ago
Quanome Advances Its AI Cloud Business XDT with US$18.8 Million Infrastructure Purchase Agreement
Company Advances Development of First U.S. AI Infrastructure Hub, Executes Its Quantum & AI Systems Strategy
Quanome Advances Its AI Cloud Business XDT with US$18.8 Million Infrastructure Purchase Agreement
Positive
Benzinga
4 days ago
Quanome Stock Soars 80% After Agreeing to Buy 32 GPU Servers
Quanome Technologies Inc. (NASDAQ:QNME) shares are trading higher Tuesday after the company announced it entered into a Purchase and Sale Agreement and related purchase order with Compal Electronics for the purchase of 32 GPU server units.
Quanome Stock Soars 80% After Agreeing to Buy 32 GPU Servers
Neutral
GlobeNewsWire
1 month ago
Quanome Technologies Establishes Global Quantum Council and Scientific Advisory Network
International expert platforms bring together scientific expertise across four quantum streams to advance understanding, collaboration and real-world application
Quanome Technologies Establishes Global Quantum Council and Scientific Advisory Network
Neutral
GlobeNewsWire
1 year ago
Lakeside Announces Fiscal 2025 Third Quarter and Nine-Month Results
ITASCA, IL, May 15, 2025 (GLOBE NEWSWIRE) -- Lakeside Holding Limited (“Lakeside” or the “Company”) (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market operating through two specialized subsidiaries—American Bear Logistics and Hupan Pharmaceutical (Hubei) Co., Ltd., today announced financial results for its fiscal 2025 third quarter and nine months ended March 31, 2025.
Lakeside Announces Fiscal 2025 Third Quarter and Nine-Month Results
Neutral
PRNewsWire
1 year ago
LAKESIDE HOLDING ANNOUNCES A CONVERTIBLE DEBT FINANCING OF UP TO $4.5 MILLION
ITASCA, Ill. , March 5, 2025 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market operating through two specialized subsidiaries—American Bear Logistics and Hupan Pharmaceutical (Hubei) Co., Ltd.
LAKESIDE HOLDING ANNOUNCES A CONVERTIBLE DEBT FINANCING OF UP TO $4.5 MILLION
Neutral
PRNewsWire
1 year ago
Lakeside Announces Fiscal 2025 Second Quarter and Six-Month Results
ITASCA, Ill. , Feb. 14, 2025 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market operating through two specialized subsidiaries—American Bear Logistics and Hupan Pharmaceutical (Hubei) Co., Ltd.
Lakeside Announces Fiscal 2025 Second Quarter and Six-Month Results
Neutral
PRNewsWire
1 year ago
Lakeside Secures New Distribution Agreements with Kelun Pharmaceutical
Expanding Partnerships with Major Industry Players ITASCA, Ill. , Jan. 21, 2025 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market is pleased to announce that its wholly owned subsidiary, Hupan Pharmaceutical (Hubei) Co., Ltd.
Lakeside Secures New Distribution Agreements with Kelun Pharmaceutical
Neutral
PRNewsWire
1 year ago
Lakeside Partners with Huiyu Pharmaceutical to Revolutionize Oncology Drug Distribution
ITASCA, Ill. , Jan. 7, 2025 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market today announced that Hupan Pharmaceutical has entered into a strategic distribution agreement with Sichuan Huiyu Pharmaceutical Co., Ltd.
Lakeside Partners with Huiyu Pharmaceutical to Revolutionize Oncology Drug Distribution
Neutral
PRNewsWire
1 year ago
Lakeside Signs $1.5 Million Sales Agreement with Sinopharm Group Subsidiary
Agreement to Deliver Critical Medicines  ITASCA, Ill. , Dec. 17, 2024 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based cross-border supply chain solution provider with a unique focus on the Asia-Pacific market is pleased to announce that Hupan Pharmaceutical has signed a Sales Agreement (the "Agreement") with Sinopharm Holding Hubei New Special Medicine Co., Ltd.
Lakeside Signs $1.5 Million Sales Agreement with Sinopharm Group Subsidiary
Neutral
PRNewsWire
1 year ago
Lakeside Holding to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference
ITASCA, Ill , Dec. 3, 2024 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market operating under the brand American Bear Logistics ("ABL"), today announced it will be presenting at The Benchmark Company's 13th Annual Discovery One-on-One Investor Conference to be held Wednesday, December 11th, 2024 at the New York Athletic Club in New York City. The conference offers emerging growth, and dynamic publicly traded companies access to institutional and individual investors in a unique one-on-one format during which Henry Liu, CEO of Lakeside will be participating in one-on-one meetings with investors and analysts throughout the day.
Lakeside Holding to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference
Price charts implemented using Lightweight Charts™